Stemedica Awarded U.S. Patent for Transgenic Therapeutic Stem Cells

SAN DIEGO, Aug. 13, 2015 /PRNewswire/ — Stemedica Cell Technologies, Inc., a leading manufacturer of adult, allogeneic stem cells and stem cell factors, received United States Patent No. 9080184 entitled “Transgenic Therapeutic Stem Cells and Methods for …

[Read the full article here]

Comments are closed.